Welcome to the e-CCO Library Archive!

Filter:

E. McDermott¹, V. Kale¹, N. Rafter¹, D. Keegan¹, K. Byrne¹, M. Forry², G. Doherty¹, G. Cullen¹, K. Malone³, S. Patchett², H. Mulcahy¹, ¹St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland, ²Beaumont Hospital, Department of Gastroenterology, Dublin, Ireland, ³St Vincent's University Hospital, Department of Psychiatry, Dublin, Ireland

P162

Is Sensorineural Hearing Loss Frequent in Patients With Inflammatory Bowel Disease? Preliminary Results Of Ongoing Study

Authors:

G. Sirin*¹, O. Senturk¹, A. Celebi¹, S. Sirin², S. Hulagu¹

¹Kocaeli University, Gastroenterology, Kocaeli, Turkey, ²Seka State Hospital, ENT Department, Kocaeli, Turkey

P163.

Predictive value of early restoration of quality of life in Crohn's disease patients receiving antiTNF agents

Authors:

C. Herrera, V. Robles, N. Borruel, E. Navarro, A. Torrejón, F. Casellas, Unitat Atenció Crohn-Colitis. Hospital Universitari Vall d'Hebron, Digestive System Research Unit, Barcelona, Spain

P163. Outcomes of treatment with infliximab for ulcerative colitis and predictors of sustained clinical response

P163. Quality of life for patients with deep remission vs. clinical remission and deep remission vs. absence of mucosal ulceration: 3-year data from CHARM/ADHERE

Authors:

J.-F. Colombel¹, R. Panaccione², E. Louis³, M. Yang⁴, M. Skup⁴, P.F. Pollack⁴, R.B. Thakkar⁴, A. Camez⁴, P.M. Mulani⁴, J. Chao⁴, W.J. Sandborn⁵, ¹Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, Lille, France, ²University of Calgary, Calgary, Alberta, Canada, ³University of Liège and CHU Liège, Liège, Belgium, ⁴Abbott Laboratories, Abbott Park, IL, United States, ⁵University of California, San Diego, La Jolla, CA, United States

P163. Vitamin D deficiency in IBD patients at diagnosis and its relationship with disease location and activity: A cohort study in 2 UK IBD centres

P163

Where do patients go for information on Inflammatory Bowel Disease (IBD)?

Authors:

V. Warren, A. Rehman, C. Williams, S. Mumtaz, H. Bholah, D. Gracie, J. Hamlin, A. Ford, C. Selinger*

St Jame's University Hospital, Center for Digestive Diseases, Leeds, United Kingdom

P164.

Predictive factors of the course of Crohn's disease – can we treat in anticipation?

Authors:

F. Dias de Castro, J. Magalhães, P. Boal Carvalho, M.J. Moreira, J. Cotter, Centro Hospitalar do Alto Ave, Gastroenterology, Guimaraes, Portugal

P164. Free DNA level in patients with inflammatory bowel diseases

P164. Quality of life in inflammatory bowel disease patients with and without arthropathies: a prospective longitudinal study with 12-months follow-up

Authors:

L. Brakenhoff¹, R. van den Berg², F. van Gaalen², A. van der Meulen-de Jong¹, T. Huizinga², D. Hommes³, D. van der Heijde², H. Fidder⁴, ¹Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, Netherlands, ²Leiden University Medical Center, Rheumatology, Leiden, Netherlands, ³University of California Los Angeles, Center for Inflammatory Bowel Diseases, Los Angeles, United States, ⁴University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, Netherlands

P164. Safety of biological therapy during pregnancy in women with inflammatory bowel disease: Experience of a single centre

P164

Evaluation of an interim Crohn's disease outcome measure (PRO-2) based on two patient-reported components (stool frequency, abdominal pain) of the Crohn's Disease Activity Index (CDAI) in the ustekinumab CERTIFI Study

Authors:

C. Gasink¹, J. Friedman¹, L.L. Gao¹, D. Chan*¹, W.J. Sandborn², B. Feagan³

¹Janssen Research and Development, LLC, Immunology, Spring House, United States, ²University of California San Diego, Division of Gastroenterology , La Jolla, United States, ³Robarts Clinical Trials Inc., Robarts Research Institute, University of Western Ontario, London, Ontario, Canada

P165.

Predictive factors for chronic inflammatory bowel diseases in patients presenting with new onset diarrhea

Authors:

A.-M. Singeap¹, A. Trifan¹, I. Girleanu¹, O.C. Stoica¹, C. Stanciu², ¹University of Medicine and Pharmacy “Gr. T. Popa” Iasi, Institute of Gastroenterology and Hepatology, Iasi, Romania, ²Institute of Gastroenterology and Hepatology, Gastroenterology, Iasi, Romania

P165. Endoscopic treatment of dysplasia in ulcerative colitis – median term outcome

P165. Pseudotumoral colonic form of Crohn's disease: a series of 16 cases

Authors:

M. Fekih¹, M. Cheikh¹, A. Laabidi¹, H. Debbabi¹, N. Ben Mustapha², J. Boubaker¹, L. Kallel¹, A. Filali¹, ¹La Rabta hospital; Tunis El Manar university, Gastroenterology “A”, Tunis, Tunisia, ²La Rabta Hospital, Gastro A Unit, Tunis, Tunisia

P165. Small intestine contrast ultrasonography (SICUS) for the assessment of intestinal strictures in Crohn's disease: A prospective comparative study vs pathological, histological, morphometric findings

P165

The distribution and severity of small bowel inflammatory activity forecast the emergence of anemia and nutricional deficits in Crohn's Disease

Authors:

P. Boal Carvalho*¹, F. Dias de Castro¹, B. Rosa¹, M.J. Moreira¹, J. Cotter^{1, 2, 3}

¹Centro Hospitalar do Alto Ave, Gastroenterology, Guimaraes, Portugal, ²Universidade do Minho, Life and Health Sciences Research Institute, Braga/Guimarães, Portugal, ³ICVS/3B’s , PT Associate Laboratory, Braga/Guimarães, Portugal

P166.

Predictive factors for anatomic extent of lesions in patients affected by ulcerative colitis

Authors:

E. Lolli, P. Scarozza, A. Bella, S. Onali, G. Condino, F. Zorzi, M. Ascolani, C. Petruzziello, L. Biancone, F. Pallone, E. Calabrese, Gastroenterology Unit, University of Rome Tor Vergata, Department of Systems Medicine, Rome, Italy

P166. Efficacy of intensification regimes of biologic therapy in patients with inflammatory bowel disease and secondary non-response: Experience of a single referral centre


All Abstracts Documents Images Podcasts Webcasts
search by: